CureSign is a company headquartered in Germany.
CureSign develops a medical device combining advanced sensors, signal processing, and big data tools to enable personalized cancer treatment and preclinical oncology trials.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.